MAI Capital Management’s Health Catalyst HCAT Stock Holding History

MAI Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-147	Closed	-$187	–	3199
2026 Q1	$187	Buy	+147	New	+$277	﹤0.01%	4641

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MAI Capital Management's HCAT Position: Q2 2026 in Review

MAI Capital Management sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 147 shares — an estimated $187 sold.

MAI Capital Management first reported a position in HCAT in Q1 2026 and held it in 1 quarter. The position peaked at $187 in Q1 2026. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

MAI Capital Management reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 147 Health Catalyst shares in Q2 2026, an estimated $187.
MAI Capital Management first reported a position in Health Catalyst in Q1 2026 and held it in 1 quarter.
MAI Capital Management's Health Catalyst position peaked at $187 in Q1 2026.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.